Privia Health (PRVA)
Organizes physician practices with technology, administration, and value-based-care infrastructure.
Something off on this page? Send us feedback.
Organizes community physician practices into regional medical groups and value-based-care networks, supplying technology, administration, payer contracting, and population-health services. Revenue comes from fee-for-service care and administration, capitation, shared savings, care-management fees, and ancillary services, while many affiliated practices remain physician-owned.
Organizes independent physicians and clinicians into regional, primary-care-centric networks through Privia Medical Group, while Privia Care Partners connects practices seeking only value-based-care support. Across U.S. markets, the Privia Platform combines workflow technology with revenue-cycle management, payer contracting, analytics, and practice operations.
Earns fee-for-service patient-care and administrative revenue, plus capitation, shared savings, care-management fees, and ancillary-service revenue. Local physician governance and continued practice ownership preserve clinical autonomy, while centralized medical groups, management-services organizations, and accountable care organizations coordinate reimbursement and population health.
Some medical groups are owned or consolidated; others are served under management agreements or state-specific friendly-physician structures. The model depends on provider affiliations, payer and health-system relationships, government reimbursement programs, healthcare and privacy rules, and an athenahealth-based electronic medical record.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 7, 2026 | Canaccord Genuity | Target | Target: $34 | Target: $32 |
| May 26, 2026 | Barclays | Reiterate | Rating: —Target: $22 | Target: $24 |
| Apr 8, 2026 | Evercore ISI | Target | Target: $22 | Target: $26 |
| Feb 26, 2026 | Jefferies | Target | Target: — | Target: $32 |
| Feb 26, 2026 | Piper Sandler | Target | Target: $40 | Target: $36 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $412.20B · Total debt $8.73B · Total assets $1.49T · Shareholders' equity $782.33B
- Revenue
- $632.6M
- Operating income
- $11.8M
- Net income
- $9.0M
No dividends on record.
| Institutions | 99.14% | 124.92M shares | |
|---|---|---|---|
| 306 holders · as of Jun 30, 2026 | |||
| Insiders | 0.86% | 1.08M shares | |
| 14 holders · as of Sep 3, 2026 | |||
| Other | 0.00% | 6.8K shares | |
| remainder | |||
126.01M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 16.98% | 21.40M | as of Jun 30, 2026 |
FMR LLCInstitution | 10.20% | 12.85M | as of Jun 30, 2026 |
Durable Capital Partners LPInstitution | 9.23% | 11.64M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.22% | 6.57M | as of Jun 30, 2026 |
Rubicon Founders LLCInstitution | 4.74% | 5.97M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 9, 2026 | David Mountcastle | officer: EVP & Chief Financial Officer | −21,275 | $27.67 |
| Jul 7, 2026 | David Mountcastle | officer: EVP & Chief Financial Officer | −600 | $27.57 |
| Jul 2, 2026 | David Mountcastle | officer: EVP & Chief Financial Officer | −24,734 | $27.50 |
| Jul 6, 2026 | Matthew Shawn Morris | director | −53,722 | $27.24 |
| Jul 2, 2026 | Matthew Shawn Morris | director | −59,037 | $27.33 |
- Agilon Health
Physician enablement and MA value-based care peer.
- Astrana Health
Provider-centric VBC and care-enablement platform.
- UnitedHealth Group
Optum scale competitor in VBC and provider services.
- Humana
CenterWell senior primary-care and VBC MSO rival.
- CVS Health
Oak Street and Signify overlap in value-based care.
- P3 Health Partners
Physician-led MA population-health competitor.
- Evolent
Adjacent specialty-care VBC infrastructure peer.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Privia Health | $19.84 | +1.51% | $2.46B | 90.1 | 51.6 | 1.0 | +21.4% |
| Agilon Health | $88.72 | +0.78% | $1.47B | — | — | 0.2 | +7.2% |
| Astrana Health | $34.55 | +2.97% | $1.66B | 41.0 | 20.9 | 0.4 | +48.5% |
| UnitedHealth Group | $373.99 | −0.95% | $342.88B | 24.3 | 17.5 | 0.8 | +0.4% |
| Humana | $372.95 | −1.49% | $45.39B | 35.9 | 30.3 | 0.3 | +26.2% |
| CVS Health | $87.51 | −0.11% | $111.77B | 23.2 | 10.8 | 0.3 | +7.3% |
| P3 Health Partners | $7.81 | +2.76% | $24.9M | — | — | 0.0 | +8.6% |
| Evolent | $3.71 | +0.41% | $415.1M | — | 11.0 | 0.2 | +46.9% |
| Median | 30.1 | 17.5 | 0.3 | +8.6% |